Assess Efficacy and Safety of the Dopamine Agonist Pramipexole Versus Levodopa / Benserazide (Madopar® DR) in Patients With Restless Legs Syndrome

NCT00144209 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

Restless Legs Syndrome

Interventions

DRUG: pramipexole
DRUG: levodopa in combination with benserazide

Sponsor

Boehringer Ingelheim